PURPOSE: Preclinical studies demonstrate that cardiac glycosides such as ouabain and digoxin have antitumor effects on retinoblastoma cells in vitro and in a xenograft murine model of retinoblastoma. METHODS: Based on these findings, we report a case of intra-arterial followed by systemic oral digoxin therapy in a patient with unilateral retinoblastoma that had failed prior intra-arterial chemotherapy. RESULTS: Oral administration of digoxin produced no effect, while intra-arterial digoxin therapy produced a modest but measurable response that was likely limited by the inability to achieve sustained drug concentration in the eye. CONCLUSIONS: This case highlights both the potential promise and limitations of cardiac glycoside therapy in retinoblastoma.
PURPOSE: Preclinical studies demonstrate that cardiac glycosides such as ouabain and digoxin have antitumor effects on retinoblastoma cells in vitro and in a xenograft murine model of retinoblastoma. METHODS: Based on these findings, we report a case of intra-arterial followed by systemic oral digoxin therapy in a patient with unilateral retinoblastoma that had failed prior intra-arterial chemotherapy. RESULTS: Oral administration of digoxin produced no effect, while intra-arterial digoxin therapy produced a modest but measurable response that was likely limited by the inability to achieve sustained drug concentration in the eye. CONCLUSIONS: This case highlights both the potential promise and limitations of cardiac glycoside therapy in retinoblastoma.
Authors: Bhavneet Bhinder; Christophe Antczak; David Shum; Constantin Radu; Jeni P Mahida; Nancy Liu-Sullivan; Glorymar Ibanez; Balajee Somalinga Raja; Paul A Calder; Hakim Djaballah Journal: Comb Chem High Throughput Screen Date: 2014-05 Impact factor: 1.339
Authors: Anthony B Daniels; Michael T Froehler; Janene M Pierce; Amy H Nunnally; M Wade Calcutt; Thomas M Bridges; David C LaNeve; Phillip E Williams; Kelli L Boyd; Michelle L Reyzer; Craig W Lindsley; Debra L Friedman; Ann Richmond Journal: Invest Ophthalmol Vis Sci Date: 2018-01-01 Impact factor: 4.799
Authors: Paula Schaiquevich; Jasmine H Francis; María Belén Cancela; Angel Montero Carcaboso; Guillermo L Chantada; David H Abramson Journal: Front Oncol Date: 2022-04-01 Impact factor: 5.738
Authors: Jeni P Mahida; Christophe Antczak; Daniel Decarlo; Kathryn G Champ; Jasmine H Francis; Brian Marr; Arthur S Polans; Daniel M Albert; David H Abramson; Hakim Djaballah Journal: PLoS One Date: 2013-03-19 Impact factor: 3.240